HPE
70
2
DFS
67
-3
TXN
49
-6
LB
63
-4
DLTR
40
4
EXPE
96
-3
EMN
50
-2
GLW
48
-5
R
77
2
JBHT
63
-5
XEL
65
-2
EW
32
3
STZ
58
3
SWK
56
-6
PAYX
57
-2
MU
32
-6
SYY
47
-2
MAT
38
-3
ETR
68
-3
LEG
31
3
HPE
70
2
DFS
67
-3
TXN
49
-6
LB
63
-4
DLTR
40
4
EXPE
96
-3
EMN
50
-2
GLW
48
-5
R
77
2
JBHT
63
-5
XEL
65
-2
EW
32
3
STZ
58
3
SWK
56
-6
PAYX
57
-2
MU
32
-6
SYY
47
-2
MAT
38
-3
ETR
68
-3
LEG
31
3
Financhill
Back

First Trust Enhanced Short Maturity ETF Vs. Neurogene Industry Stock Comparison

Sell
46

FTSM
First Trust Enhanced Short Maturity ETF

Last Price:
59.87
Seasonality Move:
0%
Sell
5

NGNE
Neurogene

Last Price:
39.61
Seasonality Move:
50.43%
Sell
46
First Trust Enhanced Short Maturity ETF (FTSM) is a Sell

Is First Trust Enhanced Short Maturity ETF a Buy, Sell or Hold?

  • The current First Trust Enhanced Short Maturity ETF [FTSM] share price is $59.86. The Score for FTSM is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • FTSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
5
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

FTSM Stock Price Chart

What is First Trust Enhanced Short Maturity ETF's stock price today?

  • The First Trust Enhanced Short Maturity ETF share price today is $59.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FTSM is experiencing selling pressure, which indicates risk of future bearish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $39.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

FTSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 44.1 Sell
Chaikin Money Flow: -621081 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.84 - 60) Sell
Bollinger Bands (100): (59.79 - 60.01) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.3 Buy
Relative Strength Index (14 RSI): 39.1 Sell
Chaikin Money Flow: -346626 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.29 - 61.53) Sell
Bollinger Bands (100): (34.11 - 50.51) Sell

FTSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.84 Buy
20-day SMA: 59.91 Sell
50-day SMA: 59.95 Sell
200-day SMA: 59.81 Buy
8-day EMA: 59.85 Buy
20-day EMA: 59.89 Sell
50-day EMA: 59.92 Sell
200-day EMA: 59.83 Buy

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.39 Sell
20-day SMA: 53.17 Sell
50-day SMA: 46.66 Sell
200-day SMA: 38.93 Buy
8-day EMA: 54.03 Sell
20-day EMA: 53.18 Sell
50-day EMA: 48.36 Sell
200-day EMA: 38.47 Buy

First Trust Enhanced Short Maturity ETF Earnings Growth & FTSM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

First Trust Enhanced Short Maturity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):